Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Karenitecin (BNP1350) to Treat Malignant Melanoma
This study has been completed.
Study NCT00062491   Information provided by BioNumerik Pharmaceuticals, Inc.
First Received: June 6, 2003   Last Updated: April 1, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma
Neoplasm
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
Karenitecin (BNP1350)
Sponsors listed in this trial
BioNumerik Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services